In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gadoterate Meglumine Drug Master File in Korea (Gadoterate Meglumine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gadoterate Meglumine. The MFDS reviews the Gadoterate Meglumine KDMF as part of the drug registration process and uses the information provided in the Gadoterate Meglumine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gadoterate Meglumine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gadoterate Meglumine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gadoterate Meglumine suppliers with KDMF on PharmaCompass.